(Q42230165)

English

Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection

scientific article published on 20 March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

Philip Kiely

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Angelo R Margaritis

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hung Yang

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Australian Red Cross Blood Service NAT Study Group

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

20 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

2084-2091

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Assessing the impact of HBV NAT on window period reduction and residual risk

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Transfusion-transmitted hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Hepatitis B virus infection and transfusion medicine: science and the occult

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Occult hepatitis B virus infection: implications in transfusion

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Italian blood donors with anti-HBc and occult hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Characterization of occult hepatitis B virus strains in South African blood donors

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Molecular characterization of occult hepatitis B cases in Greek blood donors.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Occult hepatitis B virus infection in Thai blood donors

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

The clinical significance of occult hepatitis B transfusion in Taiwan--a look-back study.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Infectivity of blood products from donors with occult hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12556

21 January 2018

Identifiers

10.1111/TRF.12556

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42230165&oldid=1937132612"